LS Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,401
| Closed | -$78K | – | 836 |
|
|
2020
Q2 | $78K | Hold |
2,401
| – | – | ﹤0.01% | 1056 |
|
|
2020
Q1 | $98K | Hold |
2,401
| – | – | 0.01% | 902 |
|
|
2019
Q4 | $148K | Buy |
2,401
+2,088
| +667% | +$129K | 0.01% | 946 |
|
|
2019
Q3 | $23K | Hold |
313
| – | – | ﹤0.01% | 1499 |
|
|
2019
Q2 | $26K | Hold |
313
| – | – | ﹤0.01% | 1476 |
|
|
2019
Q1 | $22K | Hold |
313
| – | – | ﹤0.01% | 1487 |
|
|
2018
Q4 | $14K | Sell |
313
-1,110
| -78% | -$49.6K | ﹤0.01% | 1554 |
|
|
2018
Q3 | $80K | Sell |
1,423
-376
| -21% | -$21.1K | ﹤0.01% | 1185 |
|
|
2018
Q2 | $120K | Buy |
1,799
+45
| +3% | +$3K | 0.01% | 1089 |
|
|
2018
Q1 | $102K | Buy |
1,754
+50
| +3% | +$2.91K | 0.01% | 1107 |
|
|
2017
Q4 | $110K | Sell |
1,704
-634
| -27% | -$40.9K | 0.01% | 1118 |
|
|
2017
Q3 | $123K | Buy |
2,338
+597
| +34% | +$31.4K | 0.01% | 1094 |
|
|
2017
Q2 | $81K | Hold |
1,741
| – | – | 0.01% | 1195 |
|
|
2017
Q1 | $86K | Buy |
1,741
+1,410
| +426% | +$69.7K | 0.01% | 1168 |
|
|
2016
Q4 | $20K | Hold |
331
| – | – | ﹤0.01% | 1546 |
|
|
2016
Q3 | $22K | Buy |
331
+38
| +13% | +$2.53K | ﹤0.01% | 1483 |
|
|
2016
Q2 | $16K | Buy |
293
+18
| +7% | +$983 | ﹤0.01% | 1544 |
|
|
2016
Q1 | $9K | Hold |
275
| – | – | ﹤0.01% | 1645 |
|
|
2015
Q4 | $12K | Hold |
275
| – | – | ﹤0.01% | 1601 |
|
|
2015
Q3 | $11K | Hold |
275
| – | – | ﹤0.01% | 1622 |
|
|
2015
Q2 | $17K | Buy |
+275
| New | +$17K | ﹤0.01% | 1550 |
|